These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 715674)

  • 41. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased gentamicin dosage requirements: rapid elimination in 249 gynecology patients.
    Zaske DE; Cipolle RJ; Strate RG; Dickes WF
    Am J Obstet Gynecol; 1981 Apr; 139(8):896-900. PubMed ID: 7223791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.
    Yu T; Stockmann C; Healy DP; Olson J; Wead S; Neely AN; Kagan RJ; Spigarelli MG; Sherwin CM
    J Burn Care Res; 2015; 36(4):e244-52. PubMed ID: 25185930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
    Lode H; Grunert K; Koeppe P; Langmaack H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1312-7. PubMed ID: 782811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amikacin pharmacokinetics in young men with pneumonia.
    Bauer LA; Blouin RA
    Clin Pharm; 1982; 1(4):353-5. PubMed ID: 7185529
    [No Abstract]   [Full Text] [Related]  

  • 47. Intraventricular levels of amikacin after intravenous administration.
    Yogev R; Kolling WM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):583-6. PubMed ID: 7325626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
    Marik PE; Havlik I; Monteagudo FS; Lipman J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.
    Labaune JM; Bleyzac N; Maire P; Jelliffe RW; Boutroy MJ; Aulagner G; Putet G
    Biol Neonate; 2001 Aug; 80(2):142-7. PubMed ID: 11509814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amikacin dosage in the preterm newborn.
    Want SV; Jones AK; Darrell JH
    J Antimicrob Chemother; 1979 Sep; 5(5):527-30. PubMed ID: 500515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases.
    Howard JB; McCraken GH; Trujillo H; Mohs E
    Antimicrob Agents Chemother; 1976 Aug; 10(2):205-10. PubMed ID: 984762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations.
    Vaidyanathan S; Peloquin C; Wyndaele JJ; Buczynski AZ; Almog Y; Markantonis SL; Jayawardena V; Soni BM; Cannon J; Vidal J
    ScientificWorldJournal; 2006 Feb; 6():187-99. PubMed ID: 16493523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Aminoglycoside drip intravenous infusion for severe infections due to leukemia and hematopoietic tumor patients (author's transl)].
    Fujioka S; Asai T; Ito K; Sugiura Y; Oh H
    Jpn J Antibiot; 1981 Jan; 34(1):7-15. PubMed ID: 7241808
    [No Abstract]   [Full Text] [Related]  

  • 55. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.
    Orsini JA; Soma LR; Rourke JE; Park M
    J Vet Pharmacol Ther; 1985 Jun; 8(2):194-201. PubMed ID: 4020950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amikacin serum concentrations: prediction of levels and dosage guidelines.
    Sarubbi FA; Hull JH
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):612-8. PubMed ID: 717929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial dosage regimens of gentamicin in patients with burns.
    Zaske DE; Chin T; Kohls PR; Solem LD; Strate RG
    J Burn Care Rehabil; 1991; 12(1):46-50. PubMed ID: 2022681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical evaluation of ototoxicity associated with intravenous drip infusion of amikacin].
    Maeyama T; Hashimoto M; Ogawa K; Hanamure Y; Kiyota R; Kurono Y; Iida F; Ohhori Y; Ogawa K
    Jpn J Antibiot; 1983 Oct; 36(10):2813-9. PubMed ID: 6674516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experimental and clinical studies of intravenous infusion of amikacin in acute respiratory tract infections].
    Ito T
    Jpn J Antibiot; 1982 Aug; 35(8):2111-25. PubMed ID: 7154253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.